Biologics & Biosimilars
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Feb 2026 · 8 mo ago
Grants
$976k
4 grants · CORDIS
The money's age
Fresh money
8 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Feb 11
Raised a round Venture round
Apr 1, 2025
Won a grant $413k · CORDIS
Oct 1, 2024
Won a grant $11k · CORDIS
Oct 18, 2022
Raised a round Venture round
May 1, 2022
Won a grant $330k · CORDIS
Oct 1, 2020
Won a grant $221k · CORDIS
Jun 26, 2017
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Feb 2026 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Apr 2025 | $413k | — | CORDIS |
| Grant | Oct 2024 | $11k | — | CORDIS |
| Venture round | Oct 2022 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | May 2022 | $330k | — | CORDIS |
| Grant | Oct 2020 | $221k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | DARESBURY PROTEINS LTD. | Companies House |
| Registered | 26 Jun 2017 |
Investors in similar startupsfunds that back the companies most like this one

backs Core Biogenesis

backs Genosys Bio
Similar startupsby what they do, their industry and backers

High-throughput cell line development for biopharmaceuticals. DNA barcoding platform that screens thousands of CHO cell lines…

Cocoon Bioscience’s recombinant protein expression system uses natural bioreactors to produce affordable, scalable, and effective products.

Core Biogenesis grows recombinant proteins and peptides in plant cells , research-grade purity, industrial yield, low carbon footprint…

Trellis Bioscience is developing native human antibodies to disrupt bacterial biofilms and address difficult-to-treat infections.

0 The Operating System for Biologics Manufacturing Genosys Bio designs gene-expression systems that deliver more medicine using the same…

Explore Therapeutic Protein Libraries. For decades, therapeutic antibody discovery and optimization has been a shot in the Dark With the…
Overview
Daresbury Proteins Ltd is specialising in mammalian recombinant protein production and cell line development. We are producing authentic mammalian recombinants such as difficult-to-express proteins as reagents or candidate targets.
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Warrington
United Kingdom
HQ
Daresbury
United Kingdom
Regional office
Keckwick Lane, Daresbury, England, WA4 4FS, GB
Financials
Total raised
$976k
Latest round
Venture - Series Unknown
Funding rounds
6




